Commerce Bank’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$246K Sell
16,278
-64
-0.4% -$1.12K ﹤0.01% 1230
2026
Q1
$313K Sell
16,342
-290
-2% -$6.3K ﹤0.01% 1115
2025
Q4
$366K Sell
16,632
-125
-0.7% -$2.26K ﹤0.01% 1001
2025
Q3
$203K Sell
16,757
-28,345
-63% -$384K ﹤0.01% 1192
2025
Q2
$841K Buy
45,102
+13,335
+42% +$264K 0.01% 683
2025
Q1
$609K Buy
31,767
+4,878
+18% +$143K ﹤0.01% 772
2024
Q4
$969K Buy
26,889
+4,725
+21% +$160K 0.01% 644
2024
Q3
$940K Buy
22,164
+6,437
+41% +$273K 0.01% 663
2024
Q2
$634K Hold
15,727
﹤0.01% 766
2024
Q1
$557K Buy
15,727
+165
+1% +$4.42K ﹤0.01% 820
2023
Q4
$460K Buy
+15,562
New +$323K ﹤0.01% 878

Other funds holding TNDM

Commerce Bank's TNDM Position: Q2 2026 in Review

Commerce Bank reduced its Tandem Diabetes Care (TNDM) stake by 0.39% in Q2 2026, selling an estimated $1.12K and leaving 16,278 shares worth $246K. The position accounts for ﹤0.01% of the portfolio, ranked #1230.

Commerce Bank first reported a position in TNDM in Q4 2023 and has held it in 11 quarters since. The position peaked at $969K in Q4 2024. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Commerce Bank held 16,278 shares of Tandem Diabetes Care worth $246K as of Q2 2026.
  • Commerce Bank sold 64 Tandem Diabetes Care shares in Q2 2026, an estimated $1.12K.
  • Tandem Diabetes Care made up ﹤0.01% of Commerce Bank's portfolio in Q2 2026, its #1230 holding.
  • Commerce Bank first reported a position in Tandem Diabetes Care in Q4 2023 and has held it in 11 quarters since.
  • Commerce Bank's Tandem Diabetes Care position peaked at $969K in Q4 2024.
  • 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Commerce Bank's 13F filing for Q2 2026, filed 12 Aug 2026.